Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Avirmax CMC Inc. Launches AAV Production with Sf Rhabdovirus-free Cell Lines (Sf-RVFtm)


HAYWARD, Calif., March 22, 2023 /PRNewswire/ -- Avirmax CMC Inc. (ACI), a cGMP-licensed CDMO, is announcing the implementation of its newly-developed Sf rhabdovirus-free cell lines (under the generic trademark of Sf-RVFtm) developed for producing recombinant adeno-associated viral vectors (rAAV).

Avirmax CMC Inc. Delivers rAAV Products with Higher Viral Safety Assurance Using Sf-RVFtm Cell Lines

As an insect cell line derived from the ovarian tissue of Spodoptera frugiperda (Sf), the Sf9 cell line in concert with recombinant baculoviruses, has been widely utilized for manufacturing biologicals, including recombinant proteins, vaccines, and rAAV-based gene therapy vectors. The Sf9 cell rAAV production system has been shown to produce high yields of rAAV products containing vector genomes. However, Sf9 cell lines persistently carries Sf rhabdovirus (Sf-RV), an enveloped, negative sense and single stranded RNA (-ssRNA) virus. Although Sf-RV is an insect-specific virus and non-infectious to mammalian and human cell lines, using a Sf-RV containing Sf9 cell line for producing biologicals has potential viral safety risks that are required to be mitigated by international regulatory authorities during biopharmaceutical production.

When using serum-free suspension culture, Avirmax CMC's Sf-RVFtm cell lines have been shown to be comparable with respect to rAAV yields and quality, relative to rAAV produced using Sf-RV parental cell lines. "By implementing our Sf-RVFtm cell lines, the Sf-RV safety margin of biologic product has been increased by more than 1 billion-fold", commented Shengjiang Shawn Liu, Ph.D., DVM, chief executive and scientific officer of the company. Avirmax CMC Inc. is now using the Sf-RVFtm cell lines in rAAV manufacturing for research and clinical development purposes. Avirmax CMC Inc. is also expanding the Sf-RVFtm cell lines to the production of other modalities including vaccines and protein drugs.

Avirmax CMC Inc. (ACI) is a subsidiary of Avirmax Inc., a San Francisco Bay Area based firm working on technological solutions to challenges associated with rAAV manufacturing and testing. Please visit us at www.avirmaxCMC.com for more information.

Contact

Please contact
June Song, Associate Director for Operations
Email : [email protected]
Tel: +1-510-641-0201

Address
25503 Whitesell Street
Hayward 94545 CA
USA

SOURCE Avirmax


These press releases may also interest you

at 12:35
MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of patients suffering from debilitating CNS...

at 12:27
This year marks the 14th anniversary of the enactment of the Affordable Care Act (ACA). Its passage was the most significant advancement of health policy since the establishment of Medicare and Medicaid in the 1960s and made healthcare accessible and...

at 12:15
ResBiotic Nutrition, Inc. (ResBiotic), the pioneering physician-developed pre/probiotic wellness scale-up, proudly announces the appointments of Stefany Nieto as Vice President of Operations and Brittany Zenner as Director of Marketing. Nieto is a...

at 12:06
Maid Sailors Cleaning Service has joined forces with Cleaning for a Reason, a non-profit organization offering free house cleaning services to cancer patients across the United States and Canada....

at 12:05
Terragia Biofuel, a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP). The company will use the capital to commercialize...

at 12:05
Float, the marketplace moving all the care that doesn't need a hospital to the home, today announced $10 million in Series A funding led by Canvas Ventures, whose General Partner Mike Ghaffary has joined Float's board, with participation from Wave...



News published on and distributed by: